Skip to content
lifestyle.buyersdesire.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vaxcyte, Inc.
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
May 8, 2026
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
March 10, 2026
Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit
March 9, 2026
←
Previous Page
1
2